Indianapolis, IN

NeuroFx is developing an innovative, cell-free secretome concentrate derived from adult adipose (fat) stem cells (NFx-101). NFx-101 has demonstrated great potential to halt brain injury caused by stroke, promote regeneration and repair of brain tissues, and, most impressively, re-establish normal function in animals.

NFx-101 is a platform technology with potential (and in many cases, pre-clinical evidence) to be used in non-neurological conditions (e.g., musculoskeletal, dermatologic, cardiovascular) as well.  NeuroFx will create value in these non-core indications by partnering with biopharmaceutical, regenerative medicine or cosmetic companies.